The global market for Cholesterol-Lowering Supplements was valued at US$ 710 million in the year 2023 and is projected to reach a revised size of US$ 973 million by 2030, growing at a CAGR of 4.6% during the forecast period.
Cholesterol-lowering supplements are dietary products designed to help reduce or maintain healthy levels of cholesterol in the body, particularly low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol. These supplements typically contain various natural ingredients that have been shown to influence cholesterol metabolism, lower LDL cholesterol, or increase high-density lipoprotein (HDL) cholesterol, often referred to as "good" cholesterol.
North American market for Cholesterol-Lowering Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cholesterol-Lowering Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cholesterol-Lowering Supplements include Inlife Pharma Private Limite, Croda International Plc, Streamline Pharma Pvt. Ltd., Himalaya Wellness Company., Pure Encapsulations LLC, Step One Foods, HERBAL CREATIONS, TCI Co. Ltd., ORGANIC INDIA Pvt. Ltd., Bioglan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cholesterol-Lowering Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholesterol-Lowering Supplements.
The Cholesterol-Lowering Supplements market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cholesterol-Lowering Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cholesterol-Lowering Supplements manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Inlife Pharma Private Limite
Croda International Plc
Streamline Pharma Pvt. Ltd.
Himalaya Wellness Company.
Pure Encapsulations LLC
Step One Foods
HERBAL CREATIONS
TCI Co. Ltd.
ORGANIC INDIA Pvt. Ltd.
Bioglan
Cargill
ADM
Holland & Barrett
Vitabiotics
Solgar
Segment by Type
Plant-Based
Animal-Based
Others
Segment by Application
Online Sales
Offline Sales
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cholesterol-Lowering Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cholesterol-Lowering Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Cholesterol-Lowering Supplements Market Overview
1.1 Product Definition
1.2 Cholesterol-Lowering Supplements by Type
1.2.1 Global Cholesterol-Lowering Supplements Market Value Comparison by Type (2024-2030)
1.2.2 Plant-Based
1.2.3 Animal-Based
1.2.4 Others
1.3 Cholesterol-Lowering Supplements by Application
1.3.1 Global Cholesterol-Lowering Supplements Market Value by Application (2024-2030)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Cholesterol-Lowering Supplements Market Size Estimates and Forecasts
1.4.1 Global Cholesterol-Lowering Supplements Revenue 2019-2030
1.4.2 Global Cholesterol-Lowering Supplements Sales 2019-2030
1.4.3 Global Cholesterol-Lowering Supplements Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cholesterol-Lowering Supplements Market Competition by Manufacturers
2.1 Global Cholesterol-Lowering Supplements Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cholesterol-Lowering Supplements Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cholesterol-Lowering Supplements Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Cholesterol-Lowering Supplements, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cholesterol-Lowering Supplements, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cholesterol-Lowering Supplements, Product Type & Application
2.7 Global Key Manufacturers of Cholesterol-Lowering Supplements, Date of Enter into This Industry
2.8 Global Cholesterol-Lowering Supplements Market Competitive Situation and Trends
2.8.1 Global Cholesterol-Lowering Supplements Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cholesterol-Lowering Supplements Players Market Share by Revenue
2.8.3 Global Cholesterol-Lowering Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cholesterol-Lowering Supplements Market Scenario by Region
3.1 Global Cholesterol-Lowering Supplements Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cholesterol-Lowering Supplements Sales by Region: 2019-2030
3.2.1 Global Cholesterol-Lowering Supplements Sales by Region: 2019-2024
3.2.2 Global Cholesterol-Lowering Supplements Sales by Region: 2025-2030
3.3 Global Cholesterol-Lowering Supplements Revenue by Region: 2019-2030
3.3.1 Global Cholesterol-Lowering Supplements Revenue by Region: 2019-2024
3.3.2 Global Cholesterol-Lowering Supplements Revenue by Region: 2025-2030
3.4 North America Cholesterol-Lowering Supplements Market Facts & Figures by Country
3.4.1 North America Cholesterol-Lowering Supplements Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cholesterol-Lowering Supplements Sales by Country (2019-2030)
3.4.3 North America Cholesterol-Lowering Supplements Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cholesterol-Lowering Supplements Market Facts & Figures by Country
3.5.1 Europe Cholesterol-Lowering Supplements Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cholesterol-Lowering Supplements Sales by Country (2019-2030)
3.5.3 Europe Cholesterol-Lowering Supplements Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cholesterol-Lowering Supplements Market Facts & Figures by Region
3.6.1 Asia Pacific Cholesterol-Lowering Supplements Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cholesterol-Lowering Supplements Sales by Region (2019-2030)
3.6.3 Asia Pacific Cholesterol-Lowering Supplements Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cholesterol-Lowering Supplements Market Facts & Figures by Country
3.7.1 Latin America Cholesterol-Lowering Supplements Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cholesterol-Lowering Supplements Sales by Country (2019-2030)
3.7.3 Latin America Cholesterol-Lowering Supplements Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cholesterol-Lowering Supplements Market Facts & Figures by Country
3.8.1 Middle East and Africa Cholesterol-Lowering Supplements Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cholesterol-Lowering Supplements Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cholesterol-Lowering Supplements Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cholesterol-Lowering Supplements Sales by Type (2019-2030)
4.1.1 Global Cholesterol-Lowering Supplements Sales by Type (2019-2024)
4.1.2 Global Cholesterol-Lowering Supplements Sales by Type (2025-2030)
4.1.3 Global Cholesterol-Lowering Supplements Sales Market Share by Type (2019-2030)
4.2 Global Cholesterol-Lowering Supplements Revenue by Type (2019-2030)
4.2.1 Global Cholesterol-Lowering Supplements Revenue by Type (2019-2024)
4.2.2 Global Cholesterol-Lowering Supplements Revenue by Type (2025-2030)
4.2.3 Global Cholesterol-Lowering Supplements Revenue Market Share by Type (2019-2030)
4.3 Global Cholesterol-Lowering Supplements Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cholesterol-Lowering Supplements Sales by Application (2019-2030)
5.1.1 Global Cholesterol-Lowering Supplements Sales by Application (2019-2024)
5.1.2 Global Cholesterol-Lowering Supplements Sales by Application (2025-2030)
5.1.3 Global Cholesterol-Lowering Supplements Sales Market Share by Application (2019-2030)
5.2 Global Cholesterol-Lowering Supplements Revenue by Application (2019-2030)
5.2.1 Global Cholesterol-Lowering Supplements Revenue by Application (2019-2024)
5.2.2 Global Cholesterol-Lowering Supplements Revenue by Application (2025-2030)
5.2.3 Global Cholesterol-Lowering Supplements Revenue Market Share by Application (2019-2030)
5.3 Global Cholesterol-Lowering Supplements Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Inlife Pharma Private Limite
6.1.1 Inlife Pharma Private Limite Company Information
6.1.2 Inlife Pharma Private Limite Description and Business Overview
6.1.3 Inlife Pharma Private Limite Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Inlife Pharma Private Limite Cholesterol-Lowering Supplements Product Portfolio
6.1.5 Inlife Pharma Private Limite Recent Developments/Updates
6.2 Croda International Plc
6.2.1 Croda International Plc Company Information
6.2.2 Croda International Plc Description and Business Overview
6.2.3 Croda International Plc Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Croda International Plc Cholesterol-Lowering Supplements Product Portfolio
6.2.5 Croda International Plc Recent Developments/Updates
6.3 Streamline Pharma Pvt. Ltd.
6.3.1 Streamline Pharma Pvt. Ltd. Company Information
6.3.2 Streamline Pharma Pvt. Ltd. Description and Business Overview
6.3.3 Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio
6.3.5 Streamline Pharma Pvt. Ltd. Recent Developments/Updates
6.4 Himalaya Wellness Company.
6.4.1 Himalaya Wellness Company. Company Information
6.4.2 Himalaya Wellness Company. Description and Business Overview
6.4.3 Himalaya Wellness Company. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Himalaya Wellness Company. Cholesterol-Lowering Supplements Product Portfolio
6.4.5 Himalaya Wellness Company. Recent Developments/Updates
6.5 Pure Encapsulations LLC
6.5.1 Pure Encapsulations LLC Company Information
6.5.2 Pure Encapsulations LLC Description and Business Overview
6.5.3 Pure Encapsulations LLC Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pure Encapsulations LLC Cholesterol-Lowering Supplements Product Portfolio
6.5.5 Pure Encapsulations LLC Recent Developments/Updates
6.6 Step One Foods
6.6.1 Step One Foods Company Information
6.6.2 Step One Foods Description and Business Overview
6.6.3 Step One Foods Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Step One Foods Cholesterol-Lowering Supplements Product Portfolio
6.6.5 Step One Foods Recent Developments/Updates
6.7 HERBAL CREATIONS
6.7.1 HERBAL CREATIONS Company Information
6.7.2 HERBAL CREATIONS Description and Business Overview
6.7.3 HERBAL CREATIONS Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.7.4 HERBAL CREATIONS Cholesterol-Lowering Supplements Product Portfolio
6.7.5 HERBAL CREATIONS Recent Developments/Updates
6.8 TCI Co. Ltd.
6.8.1 TCI Co. Ltd. Company Information
6.8.2 TCI Co. Ltd. Description and Business Overview
6.8.3 TCI Co. Ltd. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.8.4 TCI Co. Ltd. Cholesterol-Lowering Supplements Product Portfolio
6.8.5 TCI Co. Ltd. Recent Developments/Updates
6.9 ORGANIC INDIA Pvt. Ltd.
6.9.1 ORGANIC INDIA Pvt. Ltd. Company Information
6.9.2 ORGANIC INDIA Pvt. Ltd. Description and Business Overview
6.9.3 ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio
6.9.5 ORGANIC INDIA Pvt. Ltd. Recent Developments/Updates
6.10 Bioglan
6.10.1 Bioglan Company Information
6.10.2 Bioglan Description and Business Overview
6.10.3 Bioglan Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bioglan Cholesterol-Lowering Supplements Product Portfolio
6.10.5 Bioglan Recent Developments/Updates
6.11 Cargill
6.11.1 Cargill Company Information
6.11.2 Cargill Description and Business Overview
6.11.3 Cargill Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cargill Cholesterol-Lowering Supplements Product Portfolio
6.11.5 Cargill Recent Developments/Updates
6.12 ADM
6.12.1 ADM Company Information
6.12.2 ADM Description and Business Overview
6.12.3 ADM Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.12.4 ADM Cholesterol-Lowering Supplements Product Portfolio
6.12.5 ADM Recent Developments/Updates
6.13 Holland & Barrett
6.13.1 Holland & Barrett Company Information
6.13.2 Holland & Barrett Description and Business Overview
6.13.3 Holland & Barrett Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Holland & Barrett Cholesterol-Lowering Supplements Product Portfolio
6.13.5 Holland & Barrett Recent Developments/Updates
6.14 Vitabiotics
6.14.1 Vitabiotics Company Information
6.14.2 Vitabiotics Description and Business Overview
6.14.3 Vitabiotics Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Vitabiotics Cholesterol-Lowering Supplements Product Portfolio
6.14.5 Vitabiotics Recent Developments/Updates
6.15 Solgar
6.15.1 Solgar Company Information
6.15.2 Solgar Description and Business Overview
6.15.3 Solgar Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Solgar Cholesterol-Lowering Supplements Product Portfolio
6.15.5 Solgar Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cholesterol-Lowering Supplements Industry Chain Analysis
7.2 Cholesterol-Lowering Supplements Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cholesterol-Lowering Supplements Production Mode & Process
7.4 Cholesterol-Lowering Supplements Sales and Marketing
7.4.1 Cholesterol-Lowering Supplements Sales Channels
7.4.2 Cholesterol-Lowering Supplements Distributors
7.5 Cholesterol-Lowering Supplements Customers
8 Cholesterol-Lowering Supplements Market Dynamics
8.1 Cholesterol-Lowering Supplements Industry Trends
8.2 Cholesterol-Lowering Supplements Market Drivers
8.3 Cholesterol-Lowering Supplements Market Challenges
8.4 Cholesterol-Lowering Supplements Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Inlife Pharma Private Limite
Croda International Plc
Streamline Pharma Pvt. Ltd.
Himalaya Wellness Company.
Pure Encapsulations LLC
Step One Foods
HERBAL CREATIONS
TCI Co. Ltd.
ORGANIC INDIA Pvt. Ltd.
Bioglan
Cargill
ADM
Holland & Barrett
Vitabiotics
Solgar
听
听
*If Applicable.